Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30609368 | 0.76 | RPS6KB1 (0.44) | RPS6KB1AKT1 | |
| SCHEMBL3265420 | 0.75 | RPS6KB1 (0.43) | RPS6KB1AKT1 | |
| SCHEMBL10877535 | 0.75 | PARP1 (0.51) | RPS6KB1 | |
| SCHEMBL29643198 | 0.71 | RPS6KB1 (0.47) | RPS6KB1AKT1 | |
| SCHEMBL626513 | 0.70 | SIRT3 (0.42) | RPS6KB1AKT1 | |
| SCHEMBL31132417 | 0.70 | SIRT3 (0.42) | RPS6KB1AKT1 | |
| SCHEMBL15544783 | 0.69 | PARP1 (0.41) | RPS6KB1AKT1 | |
| SCHEMBL6195179 | 0.67 | PDE4B (0.47) | — | |
| SCHEMBL3663171 | 0.66 | SIRT3 (0.42) | RPS6KB1AKT1 | |
| SCHEMBL5084936 | 0.66 | CCNA2 (0.39) | RPS6KB1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040180910-A1 | Heterocycle carboxamides as antiviral agents | SCHNUTE MARK E (US) | 2004-09-16 | — | — | US | disclosed |
| US-6730682-B2 | HERPES VIRUS | PHARMACIA & UPJOHN COMPANY | 2004-05-04 | — | — | US | disclosed |
| US-20020019397-A1 | Heterocycle carboxamides as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180910-A1 | Heterocycle carboxamides as antiviral agents | ZC3HAV1, ZC3HAV1L, HDAC1 | RPS6KB1 1386/4885AKT1 2976/4885 |
| US-20020019397-A1 | Heterocycle carboxamides as antiviral agents | ZC3HAV1, ZC3HAV1L, HDAC1 | RPS6KB1 1386/4885AKT1 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.